R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2022
Back to search
Official data from USPTO
PULMOVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PULMOVANT
ST13
US500000088176304Class
5, 42, 44
Filing
88176304
Registration
6635305
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
02/08/2022
Trademark type
Word
Nice classes
5, 42, 44
Filing date
10/31/2018
Registration date
02/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/08/2022
Last transaction
02/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Basel, CH
Examiner
ANDERSON, CASSONDRA CR
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Roivant Sciences GmbH
Representatives
ALLISON S. RICKETTS FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment of pulmonary and respiratory diseasesdisorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of pulmonary and respiratory diseasesdisorders and conditions
Class 42
Scientific and technological servicesmedical researchscientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical and biomedical research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine
Class 44
Providing health and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
26 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/23/2021
PUBO
PUBLISHED FOR OPPOSITION
11/23/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/18/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/05/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/15/2020
ALIE
ASSIGNED TO LIE
09/15/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
02/20/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/25/2019
GNSL
LETTER OF SUSPENSION E-MAILED
07/25/2019
CNSL
SUSPENSION LETTER WRITTEN
07/25/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/22/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/22/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2019
GNRT
NON-FINAL ACTION E-MAILED
02/07/2019
CNRT
NON-FINAL ACTION WRITTEN
02/07/2019
DOCK
ASSIGNED TO EXAMINER
02/06/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/26/2018
ALIE
ASSIGNED TO LIE
11/21/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/15/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/12/2018
NWAP
NEW APPLICATION ENTERED
11/03/2018
Continuous trademark protection
Get notified about every new filing that threatens PULMOVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.